GILD vs KMT · P/E 18, rev $7.80B vs P/E 17, rev $2.36B
Gilead Sciences Inc (GILD) versus Kennametal Inc (KMT) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Kennametal Inc (KMT) is a tools & accessories company listed on US.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported KMT revenue for 2026-06-30 was $2.36B. Net income was $342.4M. Revenue was up 19.8% from 2025-06-30 to 2026-06-30. KMT currently screens at market cap $1.85B and trailing P/E 17.3.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. KMT currently screens at market cap $1.85B and trailing P/E 17.3.
Not investment advice. Open the GILD and KMT stock pages for the full models.
Not investment advice.